Gershenson DM - Search Results

1

Low-grade serous primary peritoneal carcinoma.

Schmeler KM, Sun CC, Malpica A, Deavers MT, Bodurka DC, Gershenson DM. Schmeler KM, et al. Among authors: gershenson dm. Gynecol Oncol. 2011 Jun 1;121(3):482-6. doi: 10.1016/j.ygyno.2011.02.017. Epub 2011 Mar 11. Gynecol Oncol. 2011. PMID: 21397305

2

Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors.

Ortiz BH, Ailawadi M, Colitti C, Muto MG, Deavers M, Silva EG, Berkowitz RS, Mok SC, Gershenson DM. Ortiz BH, et al. Among authors: gershenson dm. Cancer Res. 2001 Oct 1;61(19):7264-7. Cancer Res. 2001. PMID: 11585764

3

Ovarian serous borderline tumors with invasive peritoneal implants.

Gershenson DM, Silva EG, Levy L, Burke TW, Wolf JK, Tornos C. Gershenson DM, et al. Cancer. 1998 Mar 15;82(6):1096-103. Cancer. 1998. PMID: 9506355

4

A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancer.

Edwards CL, Herson J, Gershenson DM, Copeland LJ, Wharton JT. Edwards CL, et al. Among authors: gershenson dm. Gynecol Oncol. 1983 Apr;15(2):261-77. doi: 10.1016/0090-8258(83)90082-3. Gynecol Oncol. 1983. PMID: 6403413 Clinical Trial.

5

Utility of lymphangiography in the prediction of lymph node metastases in patients with cervical cancer.

Munkarah AR, Jhingran A, Iyer RB, Wallace S, Eifel PJ, Gershenson D, Burke TW. Munkarah AR, et al. Int J Gynecol Cancer. 2002 Nov-Dec;12(6):755-9. doi: 10.1046/j.1525-1438.2002.t01-1-01150.x. Int J Gynecol Cancer. 2002. PMID: 12445255

6

Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer.

Donato ML, Champlin RE, Wharton JT, Bodurka-Bevers D, Gershenson D. Donato ML, et al. Eur J Gynaecol Oncol. 2000;21(3):241-4. Eur J Gynaecol Oncol. 2000. PMID: 10949384

7

Loss of heterozygosity in human ovarian cancer on chromosome 19q.

Bicher A, Ault K, Kimmelman A, Gershenson D, Reed E, Liang B. Bicher A, et al. Gynecol Oncol. 1997 Jul;66(1):36-40. doi: 10.1006/gyno.1997.4709. Gynecol Oncol. 1997. PMID: 9234918

8

Unusual features of serous neoplasms of low malignant potential during pregnancy.

Mooney J, Silva E, Tornos C, Gershenson D. Mooney J, et al. Gynecol Oncol. 1997 Apr;65(1):30-5. doi: 10.1006/gyno.1996.4592. Gynecol Oncol. 1997. PMID: 9103387

9

Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapy.

Dimopoulos MA, Daliani D, Pugh W, Gershenson D, Cabanillas F, Sarris AH. Dimopoulos MA, et al. Gynecol Oncol. 1997 Mar;64(3):446-50. doi: 10.1006/gyno.1996.4583. Gynecol Oncol. 1997. PMID: 9062148 Review.

10

Ovarian involvement by serous surface papillary carcinoma.

Mulhollan TJ, Silva EG, Tornos C, Guerrieri C, Fromm GL, Gershenson D. Mulhollan TJ, et al. Int J Gynecol Pathol. 1994 Apr;13(2):120-6. doi: 10.1097/00004347-199404000-00003. Int J Gynecol Pathol. 1994. PMID: 8005732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results